Pulmonary hypertension experts Anna Hemnes, M.D., and Evan Brittain, M.D., M.Sc., moderate a panel discussion on the latest advances in pulmonary hypertension (PH) research. Panelists Thenappan Thenappan, M.D., and Corey Ventetuolo, M.D., share relevant data and research advances presented at the PHA 2022 International PH Conference and Scientific Sessions in Atlanta.
In this webinar, Laura Nowicki, RN, and PHA staff answer insurance questions. Questions from this webinar were collected and will be added to a follow-up FAQ document to ensure as many questions are answered as possible.
In this webinar, Danielle Burkett, CMA, shares Medicare insights and her knowledge from working with insurance companies and specialty pharmacies for over seven years. Learn what experts wish their patients knew about Medicare and get tips on navigating common Medicare plan challenges.
Danielle Burkett, CMA, covers the basics of Medicare and when Part A, B, C and D are used. Learn how to choose a Part D plan and understand your drug formulary. In addition, learn who needs Medicare Part C, also known as a Medicare Advantage plan.
Murali M. Chakinala, M.D., discusses how to recognize the signs and symptoms of pulmonary hypertension and hereditary hemorrhagic telangiectasia (HHT) and the importance of early diagnosis and disease management. Patients Neeta Pai and Jenna Olitsky, who live with HHT and PH, share their diagnosis journeys and how they manage both conditions.
Ronald J. Oudiz, M.D., and Traci Stewart, R.N., discuss the importance of in-person medical care to manage your pulmonary hypertension (PH). They address concerns around COVID-19 exposure and provide safety information and guidelines to help patients feel comfortable and confident when visiting their treatment centers.
The challenges of living with pulmonary hypertension during the pandemic are discussed with licensed professional counselor and support group leader Michele Freeman, MSMHC, N.C.C., L.P.C., LCSW.
Ivan Robbins, M.D., discusses CTEPH, highlights the importance of diagnosis and shares treatment options for individuals with pulmonary hypertension (PH) related to chronic thromboembolic disease.